Optiver Holding’s Amicus Therapeutics FOLD Stock Holding History

Optiver Holding’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,707	Closed	-$111K	–	2885
2026 Q1	$111K	Buy	7,707 +731	+10%	+$10.5K	﹤0.01%	882
2025 Q4	$99.3K	Buy	6,976 +5,174	+287%	+$50.8K	﹤0.01%	813
2025 Q3	$14.2K	Buy	1,802 +35	+2%	+$249	﹤0.01%	1094
2025 Q2	$10.1K	Buy	1,767 +594	+51%	+$3.83K	﹤0.01%	1005
2025 Q1	$9.57K	Buy	1,173 +487	+71%	+$4.51K	﹤0.01%	899
2024 Q4	$6.46K	Buy	686 +408	+147%	+$4.24K	﹤0.01%	826
2024 Q3	$2.97K	Sell	278 -2,995	-92%	-$32.6K	﹤0.01%	839
2024 Q2	$32.5K	Buy	+3,273	New	+$33.6K	﹤0.01%	595

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Optiver Holding's FOLD Position: Q2 2026 in Review

Optiver Holding sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 7,707 shares — an estimated $111K sold.

Optiver Holding first reported a position in FOLD in Q2 2024 and held it in 8 quarters. The position peaked at $111K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Optiver Holding reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Optiver Holding sold 7,707 Amicus Therapeutics shares in Q2 2026, an estimated $111K.
Optiver Holding first reported a position in Amicus Therapeutics in Q2 2024 and held it in 8 quarters.
Optiver Holding's Amicus Therapeutics position peaked at $111K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.